The U.S. FDA has granted the Tandem Diabetes Care clearance to market the t:flex Insulin Pump. At 480 units, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the United States. The t:flex Pump is designed for people who require more than 100 units of U-100 insulin per day, such as teenagers with type 1 diabetes and many people with type 2 diabetes, offering the benefits of pump therapy without the frequent reservoir changes required by 200- and 300-unit capacity pumps. At 480 units, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the United States.
The t:flex Pump was designed through the same user-focused development process employed with the t:slim Insulin Pump and incorporates its slim design, advanced Micro-Delivery technology, and simple-to-use touch-screen interface
The t:flex Pump is expected to launch in the United States in the second quarter of 2015.
